Portable and Lightweight Anesthesia Devices Propel Global Anesthesia Equipment Market to $11 Billion by 2028 – Latest Report – ResearchAndMarkets.com

The “Global Anesthesia Equipment Market by Type (Anesthesia Devices (Workstation, Ventilators, Monitors), Disposables (Circuits, Endotraceal Tubes)), Application (Orthopedics, Neurology, Urology), End-user (Hospitals, Clinics, ASC) and Region – Forecast to 2028” report has been added to ResearchAndMarkets.com’s offering.

The global anesthesia equipment market is projected to reach USD 11 billion by 2028 from USD 8 billion in 2023, at a CAGR of 6.7%

Growth in this market is primarily driven by the rising technological advancements in anesthesia equipment, the increasing number of surgical procedures, and the rising prevalence of chronic disorders. However, unfavorable reimbursements across healthcare systems and a shortage of medical professionals are expected to restrain the market growth to a certain extent.

The integration of new technologies (like wireless communication) has improved control of anesthesia delivery and patient monitoring during procedures. Application of artificial intelligence (AI) approaches, like machine learning, has shown a great potential to further transform the field and improve patient care. There have been several technological advancements in anesthesia equipment in recent years aimed at improving patient safety, increasing efficiency, and reducing the cost of healthcare.

The prominent players in the anesthesia equipment market include GE Healthcare (US), Dragerwerk Ag & Co. KGAA (Germany), Koninklijke Philips N.V. (Netherlands), Ambu AS (Denmark), and Medline Industries Inc. (US).

Anesthesia workstations segment accounted for a larger share of the anesthesia devices market

In 2022, the anesthesia workstations segment accounted for a larger share of the anesthesia devices market. This segment is also estimated to grow at a higher CAGR during the forecast period. Growth in this segment can primarily be attributed to the increasing number of surgical procedures and technological advancements.

The cardiology will grow at highest CAGR during the forecast period

Based on application, the cardiology will grow at highest CAGR during the forecast period. Growth in this segment can primarily be attributed to the increasing prevalence of cardiovascular diseases, the growing demand for cardiac surgeries.

Asia-Pacific will grow at highest CAGR during the forecast period

In 2022, Asia-Pacific will grow at highest CAGR during the forecast period. Major factors driving the growth of this market are the existence of a well-developed healthcare system in Japan with universal health insurance coverage and the focus of countries such as China and India on healthcare infrastructure improvements to serve large populations of patients with critical illnesses, including cancer and tumors.

Premium Insights

  • Rising Number of Surgical Procedures to Drive Market
  • Anesthesia Devices Segment in Japan Accounted for Largest Market Share in 2022
  • China to Grow at Highest CAGR During Forecast Period
  • Europe Accounted for Largest Market Share in 2022
  • Emerging Economies to Register Higher Growth Rates During Forecast Period

Market Dynamics

Drivers

  • Rising Technological Advancements in Anesthesia Equipment
  • Increasing Number of Surgical Procedures
  • High Prevalence of Chronic Diseases

Restraints

  • Unfavorable Reimbursements Across Healthcare Systems

Opportunities

  • Growth Opportunities in Emerging Economies

Challenges

  • Budgetary Constraints in Hospitals
  • Shortage of Skilled Medical Professionals

Industry Trends

  • Technological Advancements for Improved Patient Safety
  • Growing Preference for Portable and Lightweight Anesthesia Devices

Regulatory Analysis: Bodies, Government Agencies, and Other Organizations

  • North America
  • US
  • Canada
  • Europe
  • Rest of the World

Patent Analysis

  • Patent Publication Trends for Anesthesia Equipment
  • Anesthesia Equipment Market: Global Patent Publication Trends (2015-2023)
  • Top Applicants for Anesthesia Equipment Patents (2015-2023)
  • Jurisdiction Analysis: Top Applicants (Countries) for Patents

Company Profiles

Key Players

  • Koninklijke Philips N.V.
  • Ambu A/S
  • Dragerwerk AG & Co. KGaA
  • GE Healthcare
  • Beijing Aeonmed Co. Ltd.
  • Medtronic PLC
  • Getinge AB
  • Becton, Dickinson and Company
  • Shenzhen Mindray Bio-Medical Electronics Co. Ltd.
  • Fisher & Paykel Healthcare Co. Ltd.
  • Medline Industries, Inc.
  • Shenzhen Comen Medical Instruments Co. Ltd.
  • Allied Medical Limited
  • BPL Medical Technologies
  • Medec International BV
  • Skanray Technologies Ltd.

Other Companies

  • Meditec International England Ltd.
  • Penlon Limited
  • Spacelabs Healthcare
  • Teleflex Incorporated
  • Sunmed
  • Infinium Medical
  • Intersurgical, Ltd.
  • Nihon Kohden Corporation
  • Avasarala Technologies Limited
  • Axcent Medical GmbH

For more information about this report visit https://www.researchandmarkets.com/r/im2599

Hot this week

Cartessa Aesthetics Partners with Classys to Bring EVERESSE to the U.S. Market

Classys, which is listed on the KOSDAQ, is one of South Korea's most distinguished aesthetic technology manufacturers, with devices distributed in 80+ markets globally. This partnership marks Classys's official entry into the American marketplace, with Cartessa Aesthetics as the exclusive distributor for EVERESSE, launched under the Volnewmer brand in current global markets.

Stryker Launches Next-Generation of SurgiCount+

Now integrated with Stryker's Triton technology, SurgiCount+ addresses two key challenges: retained surgical sponges and blood loss assessment. Integrating these previously separate digital solutions provides the added benefit of a more efficient, streamlined workflow for hospitals notes Stryker.

Nevro Receives CE Mark In Europe for It’s HFX iQ™ Spinal Cord Stimulation System

Nevro notes HFX iQ is the first and only SCS system with artificial intelligence (AI) technology that combines high-frequency (10 kHz) therapy built on landmark evidence that uses ongoing cloud data insights to deliver personalized pain relief

Recor Medical Reports: CMS Grants Distinct TPT Device Code and Category to Recor Medical for Ultrasound Renal Denervation

The approval of TPT offers incremental reimbursement payments for outpatient procedures performed with ultrasound renal denervation for Medicare fee-for-service beneficiaries. It becomes effective January 1, 2025, and is expected to remain effective for up to three years notes Recor Medical.

Jupiter Endovascular Reports | 1st U.S. Patient Treated with Jupiter Shape-shifting Thrombectomy Device

“Navigation challenges during endovascular procedures are often underappreciated and have led to under-adoption of life-saving procedures, such as pulmonary embolectomy. We have purpose-built our Endoportal Control technology to solve these issues and make important endovascular procedures accessible to more clinicians and their patients who can benefit from them,” said Carl J. St. Bernard, Jupiter Endovascular CEO. “This first case in the U.S. could not have gone better, and appears to validate the safety and performance we are seeing in our currently-enrolling European SPIRARE I study.”
Exit mobile version